资讯
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Central to these processes are cytokines - soluble signaling proteins that orchestrate immune responses by mediating communication between cells. Cytokine networks exhibit dual functionality: they are ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
A new study shows that combining heavy alcohol use with burn trauma causes severe disruptions in the gut microbiome, leading ...
Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...
This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...
A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...
13 小时
SurvivorNet on MSNCAR T-Cell Therapy, Liso-Cel, Achieves Superior Outcomes For Patients With Hard-To-Treat ...Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.
A team of researchers from the Rice Biotech Launch Pad at Rice University in Houston developed the implantable “cytokine ...
7 小时
MedPage Today on MSNHigh Response Rate in Myeloma With Novel CAR-T After Anti-BCMA FailureOver 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果